These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19549238)

  • 1. Migraine with aura induced by efalizumab.
    Kluger N; Heroum C; Michot C; Guillot B; Bessis D
    Clin Exp Dermatol; 2009 Oct; 34(7):e401-2. PubMed ID: 19549238
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.
    de Groot M; de Rie MA; Bos JD
    Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475
    [No Abstract]   [Full Text] [Related]  

  • 3. Efalizumab-induced lupus-like syndrome.
    Durox H; Sparsa A; Loustaud-Ratti V; Prey S; Gondran G; Manea P; Vidal E; Bedane C
    Acta Derm Venereol; 2008; 88(3):270-1. PubMed ID: 18480928
    [No Abstract]   [Full Text] [Related]  

  • 4. Efalizumab-induced aseptic meningitis.
    Kluger N; Girard C; Gonzalez V; Guillot B; Bessis D
    Br J Dermatol; 2007 Jan; 156(1):189-91. PubMed ID: 17199599
    [No Abstract]   [Full Text] [Related]  

  • 5. Efalizumab-induced autoimmune pancytopenia.
    Tom WL; Miller MD; Hurley MY; Suneja T; Kudva G; Leonardi CL; Obadiah JM
    Br J Dermatol; 2006 Nov; 155(5):1045-7. PubMed ID: 17034539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent angioedema associated with efalizumab.
    Mallbris L; von Bergen F; van Hage M; Ståhle M
    Acta Derm Venereol; 2009 Nov; 89(6):665-6. PubMed ID: 19997712
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple eruptive dermatofibromas in a patient receiving efalizumab.
    Santos-Juanes J; Coto-Segura P; Mallo S; Galache C; Soto J
    Dermatology; 2008; 216(4):363. PubMed ID: 18292655
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune thrombocytopenia associated with efalizumab therapy for psoriasis.
    Warkentin TE; Kwon P
    Ann Intern Med; 2005 Nov; 143(10):761-3. PubMed ID: 16287807
    [No Abstract]   [Full Text] [Related]  

  • 9. De novo onset of arthritis in patients previously treated with efalizumab: an observational case series.
    Colina M; Cianco G; Khodeir M; Sferra S; Scanavacca P; Corazza M; Virgili A; Trotta F
    Clin Exp Rheumatol; 2011; 29(1):141. PubMed ID: 21345301
    [No Abstract]   [Full Text] [Related]  

  • 10. Efalizumab-associated thrombocytopenia.
    Hostetler SG; Zirwas M; Bechtel MA
    J Am Acad Dermatol; 2007 Oct; 57(4):707-10. PubMed ID: 17637485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab.
    Vestergaard C; Deleuran M; Kragballe K
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1272-4. PubMed ID: 17894730
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of bullous pemphigoid during treatment of psoriasis with adalimumab.
    Stausbøl-Grøn B; Deleuran M; Sommer Hansen E; Kragballe K
    Clin Exp Dermatol; 2009 Oct; 34(7):e285-6. PubMed ID: 19438555
    [No Abstract]   [Full Text] [Related]  

  • 13. Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.
    Menter A; Hamilton TK; Toth DP; Leung HM; Wetherill G; Hennessey B; Garovoy M; Kwon P; Pariser DM;
    Int J Dermatol; 2007 Jun; 46(6):637-48. PubMed ID: 17550570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.
    Gordon KB; Papp KA; Hamilton TK; Walicke PA; Dummer W; Li N; Bresnahan BW; Menter A;
    JAMA; 2003 Dec; 290(23):3073-80. PubMed ID: 14679270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis in two psoriasis patients treated with inflixmab.
    Goujon C; Dahel K; Bérard F; Guillot I; Gunera-Saad N; Nicolas JF
    J Am Acad Dermatol; 2010 Aug; 63(2):e43-4. PubMed ID: 20633783
    [No Abstract]   [Full Text] [Related]  

  • 16. [Final recommendations to incorporate efalizumab into the clinical practice].
    García-Díez A; Ferrándiz C
    Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():82. PubMed ID: 18341857
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe neutrophilia induced by infliximab for psoriasis.
    de Oliveira JP; Levy A; Morel P; Guibal F
    Br J Dermatol; 2008 Jan; 158(1):200-1. PubMed ID: 18028489
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis.
    Diluvio L; Romiti ML; Angelini F; Campione E; Rossi P; Prinz JC; Chimenti S; Lamioni A
    Br J Dermatol; 2010 Apr; 162(4):895-7. PubMed ID: 20199542
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis.
    Kluger N; Girard C; Guillot B; Bessis D
    Acta Derm Venereol; 2009; 89(3):332-4. PubMed ID: 19479148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.